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ABSTRACT
Being the largest archipelago country in the world, with a tropical climate and a unique flora and
fauna, Indonesia habitats one of the most diverse biome in the world. These characteristics make
Indonesia a popular travel destination, with tourism numbers increasing yearly. These characteris-
tics also facilitate the transmission of zoonosis and provide ideal living and breading circumstan-
ces for arthropods, known vectors for viral diseases. A review of the past 10 years of literature,
reports of the Ministry of Health, Republic of Indonesia and ProMED-mail shows a significant
increase in dengue infection incidence. Furthermore, chikungunya, Japanese encephalitis and
rabies are proven to be endemic in Indonesia. The combination of cohort studies, governmental
data and ProMED-mail reveals an integrated overview for those working in travel medicine and
public health, focusing on both endemic and emerging acute virus infections. This review sum-
marizes the epidemiology of acute virus infections in Indonesia, including outbreak reports, as
well as public health response measurements and their potential or efficacy. Knowledge about
human behaviour, animal reservoirs, climate factors, environment and their role in emerging virus
infection are discussed. We aim to support public health authorities and health care policy mak-
ers in a One Health approach.
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Introduction
Comprising thousands of islands spread across the
equator, Indonesia is the largest archipelago country in
the world with 257.5 million inhabitants (Worldbank
Indonesia Data 2016). With a broad offer of both culture
and nature, Indonesia is a popular travel destination for
travellers all over the world, with the number of travel-
lers going to Indonesia increasing yearly (World
Economic Forum 2015). Traditionally, tourists visit both
Java and Bali Island, but other islands, such as Flores,
Lombok, Sumatra, and Sulawesi gain popularity, most
likely due to effective advertisement of the islands.
However, its tropical climate and subsequent relative
high humidity are both favourable conditions for vec-
tor-borne disease transmission. In addition, Indonesia
yields a large and growing population of notorious
reservoirs of zoonotic infections like poultry, rodents,
wild birds, dogs, pigs, and monkeys (Konishi et al. 2009;
Yamanaka et al. 2010; Dash et al. 2013; Townsend et al.
2013; Lane-DeGraaf et al. 2014).
This constant tread of infection and potential local
outbreaks or even pandemics compromise both the
people living in Indonesia as well as travellers visiting
the archipelago. Infectious diseases remain one of the
leading causes of morbidity and mortality worldwide,
especially in countries with a (sub)tropical climate
(WHO 2014b). Its burden is a result of a constant
ground of established infections in the past period,
combined with epidemics of emerging infectious dis-
eases (EID) (Morens et al. 2004). An EID is characterized
as an infectious disease that appeared and affected a
population for the first time or existed before but
increased rapidly in case numbers, or geographical
spread. They often have the characteristic to easily
spread over large areas, infecting people and/or animals
with potential significant morbidity, and mortality
(WHO-SEARO 2005).
In the past decade, outbreaks of multiple emerging
infectious virus diseases (EIVD) have been reported in
Indonesia. Especially of note were those of avian
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influenza, dengue, chikungunya, and rabies (Soepandi
et al. 2010; Kosasih et al. 2013; Townsend et al. 2013;
Karyanti et al. 2014). As a result, the Indonesian govern-
ment has put much effort in trying to control many of
these diseases, for instance by implementing surveil-
lance and vector control programmes, or in the case of
rabies culling campaigns. This resulted in data of spe-
cific interest for those working with infectious disease
patients in Indonesia, public health or those working in
travel medicine outside of Indonesia. Data from local
outbreak reports and from published epidemiological
studies give a unique insight in how to optimize EIVD
prevention in Indonesia. This data potentially can be
used to support public health authorities and health
care policy makers.
EI(V)D outbreaks are hard to predict since they are
the result of a complex interaction between host, vec-
tor, pathogen, and environment. Furthermore, infec-
tions in humans often happen unnoticed, such as via
contaminated foods, mosquito bites, or inhalation of
virus-containing aerosols. From the One Health concept,
we know that six out of every 10 infectious diseases in
humans are spread from animals (CDC 2016). An opti-
mal insight in this interaction is crucial for executing
adequate preventive methods, moreover since no treat-
ment is available for the majority of acute EIVDs. A cur-
rent overview of EIVDS in Indonesia for (international)
clinicians and healthcare authorities does not seem to
be available. Furthermore, we observed that authorities
from other countries advising their inhabitants for pre-
travel vaccinations and precautions could not
adequately assess their advices since insight in local lit-
erature and governmental data for this region is lacking
(Table 1).
We, therefore, have reviewed acute (E)IVD outbreaks
in Indonesia in the past decade, using published cohort
data, ministry of health reports and reports from the
online Programme for Monitoring Emerging Diseases
(ProMED-mail). ProMED-mail is open to all sources; it
includes a variety of reports ranging from local media
to science. Data should be interpreted with care, as
reports are susceptible for information bias. Viral dis-
eases able to unnoticeably transmit from vector to
human or inter human are discussed as well. Table 2
summarizes the discussed viruses, incidence, transmis-
sion route, incubation period, symptomatology, protec-
tive actions, and diagnostic methods.
Methods
Based on manuscripts studying the epidemiology of
virus infections in South East Asia and ProMED-mail
reports, hepatitis A, West Nile virus, Japanese encephali-
tis, dengue, chikungunya, measles, rabies, hantavirus,
avian influenza, and seasonal influenza were considered
to be predominantly associated with acute human viral
Table 1. Vaccine-preventable diseases as recommendation from the Ministry of Health Republic of Indonesia, Centers for Disease
Control and Prevention, Dutch, Swiss, Singapore’s and Australian perspective.
Retrieval:
October 24 2016
Virus/authority MoH-RI (1) CDC (2) LCR (3) Swiss TPH (4) MoH-SG (5) Australian government (6)
Hepatitis A No All travellers All travellers All travellers All travellers All travellers
Hepatitis B Yes Tailored Tailoreda,b Tailoreda,c Tailored Tailored (not specified)
Japanese encephalitis No Tailoredd Tailorede Tailorede,f Tailoredd Tailored (not specified)
Measles Yes All travellers All travellers All travellers All travellers All travellers
Rabies Tailoredh Tailoredg Tailoredh Tailoredi Tailoredg Tailoredg
1) Ministry of Health, Republic of Indonesia, retrieved from: http://www.depkes.go.id.
2) Center for Diseases Control and Prevention, Department of Health and Human Service, United States of America, retrieved from http://wwwnc.cdc.gov/
travel/destinations/traveler/none/indonesia.
3) Landelijk Co€ordinatiecentrum Reizigersadvisering (National Coordination Centre for Traveladvise), the Netherlands, retrieved from https://www.mijnlcr.nl
(professionals), http://www.lcr.nl (layman).
4) Swiss Tropical and Public Health Institute, Switzerland, retrieved from http://www.safetravel.ch (available in French and German only). Supplemented
with data from Bundesamt f€ur Gesundheit BAG, retrieved from http://www.bag.admin.ch/ekif/04423/04428/ (available in German only).
5) Ministry of Health, Republic of Singapore, retrieved from https://www.moh.gov.sg/ and https://www.healthhub.sg/. The latter refers to CDC (2) for vac-
cine advice.
6) Australian Government, Department of Foreign Affairs and Trade, retrieved from http://smartraveller.gov.au/ No comprehensive travel immunization
scheme could be found.
aFor those having close contact with inhabitants, long-term stay or recreational activities with risk of injury (contaminated blood, non-sterile medical
material).
bImplemented in national vaccination programme since 2011 for all babies (ever since 1989 for specific populations, such as newborns with a hepatitis B
carrier mother).
cImplemented in national vaccination programme for all adolescents 11–15 years of age (vaccine status is checked at 25–29 years of age).
dFor those spending 1 month in endemic areas during transmission season (including 1) long-term travellers, recurrent travellers, expatriates likely to
visit rural/agriculture areas, 2) extensive outdoor (e.g. camping and farming), 3) staying in accommodation without air conditioning, screens, or bed nets.
eFor those spending 1 month on rural endemic area in close contact with rice fields and pig population.
fDuring rainy season only.
gFor those involved in outdoor activities, working with or around animals, taking long trips/moving into Indonesia, children.
hFor those with frequent and/or possible unnoticed exposure to domestic or wild mammals.
iFor those with risk of high exposure (hikers, cyclists, cave explorers and zoologists) and those spending more than 3 months in country.
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disease in SEA region (Cleton et al. 2012; WHO 2014a).
Since more recently diseases, such as Zika, hepatitis E,
and MERS-CoV (re-)emerged in the South-East Asia
region; these were taken into consideration as well. We
conducted a search of the literature for research per-
formed in Indonesia and to human cases with a history
of recent travel to Indonesia using the PubMed (includ-
ing MesH) and Embase databases from May 12 to 19
2016. Search strategy is available as supplemental data
(Supplemental data 1). Two authors independently
selected articles written in English and Bahasa
Indonesia by first reading title/abstract from human and
animal/vector studies published from May 2006 to
2016. We checked reference lists for references to rele-
vant first published data (i.e. first virus detection or clus-
ters of cases) and we extracted data when available.
Scientific literature about selected human research is
available as supplementary data (Supplemental data 2).
Figure 1 represents a map of Indonesia with a visual
overview of the locations where the discussed cohort
studies were conducted. We accessed Ministry of
Health, Republic of Indonesia (MoH-RI) and World
Health Organization (WHO) information at May 12 2016.
MoH-RI reports for 2006–2015 were available for
retrieval. Where applicable, WHO reports are referred to
in text. Furthermore, ProMED-mail was searched for
reports from Indonesia at Oct 21 2016. ProMED-mail
together with MoH-RI data is visually presented in
Figure 2 to give insight in the trends in reporting for
some EIVDs of interest and is also available as supple-
mental data (Supplemental data 2).
Dengue virus (DENV)
Dengue virus (DENV) is a Flavivirus (genus including yel-
low fever and Zika virus) belonging to the family of
Flaviviridae. DENV infection is a mosquito-borne infec-
tion caused by one of the four DENV serotypes (DENV
1–4) and is primarily transmitted to humans by the
Aedes mosquito. DENV has a worldwide distribution, is
geographically concentrated around the equator and is
endemic in Southeast Asia. The estimated number of
infections worldwide is 50–100 million, with estimated
500 000 people requiring hospitalization each year. The
incubation period is 5–8 d. Severe DENV could poten-
tially lead to haemorrhagic shock and organ failure.
Most of the symptoms become manifest around the
time of defervescence. Treatment is supportive and
mainly directed to maintenance of the body fluid
volume. Safe and effective DENV vaccines are under
Figure 1. Map of Indonesia with location overview of the discussed cohort studies conducted or reported from 2006 until May
2016 - not including case reports and/or export cases.
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development in several stages of research (Martina et al.
2009; Meltzer and Schwartz 2009; Ooi and Gubler 2009;
Chen and Wilson 2010; Mangold and Reynolds 2013;
Vannice et al. 2016). Currently, DengvaxiaVR (a tetrava-
lent, live attenuated, chimeric dengue vaccine in a yel-
low fever 17D backbone developed by Sanofi Pasteur,
Swiftwater, PA) is registered for use in individuals 9–45
years of age living in endemic areas (WHO 2016b).
However, current data does not support implementation
in the Indonesian vaccination programme.
The nationwide DENV surveillance programme
started in 1968. Besides increasing DENV incidence
numbers, surveillance showed an annual increase of
dengue haemorrhagic fever (DHF), classified as DHF
according to former classifications with at least two of
four clinical manifestations (fever, haemorrhagic mani-
festations/positive tourniquet test, hepatomegaly, and
circulatory failure combined with thrombocytopenia)
from 0.05/100 000 to 35–40/100 000 in 2013. DHF inci-
dence increased significantly in people aged 15 or
above (Karyanti et al. 2014).
DENV import cases from Indonesia were reported in
literature (Napoli et al. 2012). For instance, in Norway 2
DENV infections were reported from 2008 to 2010
(Vainio et al. 2010). Furthermore, in Italy (2010) an
imported case was reported with viremia lasting for sev-
eral days. The authors stress out the importance of per-
forming diagnostics and the potential for a local
outbreak since Aedes mosquitos are present in Italy
(and other parts of Europe) (Rovida et al. 2011).
There is data available suggesting a succeeding epi-
sode of DENV infection may lead to detrimental clinical
disease, the so-called antibody depended enhancement
theory. However, virulence seems mainly determined by
difference in genotypes and increased virulence
(Martina et al. 2009). Multiple studies report the con-
tinuous change of DENV serotypes and their lineages.
Both clustering of lineages and subtypes during out-
breaks (e.g. lineage 4 of DENV-2 between December
2011 and March 2012 (Yamanaka et al. 2011; Kotaki
et al. 2014b; Ernst et al. 2015)) as well as the concurrent
presence of all four DENV genotypes is reported in
Indonesia (Kotaki 2014a; Kotaki et al. 2014b).
Clinical studies on the epidemiology of febrile illness
in Indonesian cohorts report various rates of molecular,
antigenic or serological evidence for DENV. Overall, for
both urban and rural areas, DENV is detected in 12–55%
of all tested febrile cases; this includes all four DENV
genotypes. With a follow-up period up to seven years in
specific reports (Porter et al. 2005; Fahri et al. 2013;
Sasmono et al. 2015; Kosasih et al. 2016).
The MoH-RI national control programme in the DENV
epidemic includes surveillance of mosquito larvae in
households and eradication of mosquito breeding
spots, as a community-based programme (MoH-RI
2009). The importance of such interventions is empha-
sized by several studies: Stahl et al. showed that indirect
costs take up to 44% of the total costs (est. 2 979
902US$) per DENV outbreak (Stahl et al. 2013). Tourism
and labour flow contribute to DENV incidence, as is
Figure 2. Trends in ProMED-mail and Ministry of Health
Republic of Indonesia for the reporting of chikungunya, rabies
and avian influenzain Indonesia Reporting up till 21st October
2016. Source data ProMED-mail available as supplementary
data 2. Restricted to human cases (both laboratory confirmed
and unconfirmed), not including summarizing outbreak
reports. **indicates no data available.
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shown in field research studies in Bali – one of the most
popular islands as tourism destination. It is suggested
to reduce vector populations and spread knowledge of
vector transmittable diseases, though in this study no
effect measurements are done (Yoshikawa and
Kusriastuti 2013).
To add up, multiple manuscripts suggest adjusting
for underreporting DENV cases during an epidemic and
to analyse currently available data from cohort studies
or MoH-RI with expansion factors (Shepard et al. 2013;
Undurraga et al. 2013). Possible resistance to larvicides,
such as temephos (Mulyanto et al. 2012), understanding
the mosquito population (Rasic et al. 2015), and the
ability to predict the number of DENV cases in advance
(Halide and Ridd 2008; Wijayanti et al. 2016) all could
play an important role in further understanding of
DENV outbreaks.
West Nile virus (WNV)
West Nile virus (WNV), an arthropod-borne Flavivirus, is
a zoonotic infection mainly of birds and horses. Birds
serve as reservoir and transmission occur via mosqui-
toes. WNV is found in West Asia, as well as Africa,
Europe, Middle East, and North America (Chancey et al.
2015). Mammals are considered dead-end hosts that do
not contribute to the epidemic spread of the pathogen
(van der Meulen et al. 2005). The average incubation
period lasts 2–14 d. Of humans infected, 20% will
experience a mild, non-specific disease presentation
including high fever, headache, myalgia, sometimes
with rash, and lymphadenopathy;<1% will develop
severe neurological symptoms (Watson et al. 2004).
In Indonesia, the data regarding WNV epidemiology
is scarce. WNV was isolated from a 15-year-old patient
with fever in 2004. Phylogenetic analysis showed a rela-
tion with WNV strains isolated in Africa (Myint et al.
2014). Only limited reports of WNV in humans in
Indonesia are available. For instance, based on the work
of Nasronudin et al. (2014) and Wicaksono et al. (2014)
there is a suggestion of WNV infection in human in
Indonesia. However, these studies offer a low level of
evidence since they used a sub-optimal methodology
and confirmation by a third party lab was not per-
formed. No surveillance programme exists for WNV and
no entries exist on ProMED-mail, thus only current case
studies suggest potential circulation of WNV in
Indonesia.
Japanese encephalitis (JEV)
Japanese encephalitis virus (JEV) is an arthropod-borne
Flavivirus. It is the leading cause of encephalitis in most
of South-East Asia and Western Pacific regions, where
24 countries are known to have endemic JEV transmis-
sion (WHO 2015b). The incubation period of JEV is
6–16 d. The majority of cases are non-specific or asymp-
tomatic; only less than 1% of the individuals develop
clinical symptoms, such as fever, headache, altered
mental state, and convulsions. When encephalitis
occurs, mortality rises from 30 to 40–50% in comatose
patients. JEV is known for long-term neuropsychological
sequelae in 30–50% of those who recover from inten-
sive care support. Vaccination is considered the single
and most important control measure for JEV (Unni et al.
2011; Tiwari et al. 2012).
The first manuscript describing JEV in humans in
Indonesia dates from 1974 (Van Peenen et al. 1974).
From then, a number of cases were reported in the
80–90s in both returning travellers (Macdonald et al.
1989; Wittesjo et al. 1995; Buhl et al. 1996) as well in
Indonesian inhabitants (Yoshida et al. 1999). Early
research to JEV was done on the reservoir (pigs) (Van
Peenen et al. 1975), vector (detected in both Culex and
Anopheles species) (Van Peenen et al. 1975; Olson et al.
1985a; Olson et al. 1985b), and humans (Van Peenen
et al. 1974). Studies of Yamanaka et al. investigated JEV
viremia and antibodies in 219 pigs from Bali and East
Java in 2008. Of these pigs 49% in Bali and 6% in Java
had viremia and 24% of 123 pig samples tested in Bali
showed positive JEV IgM antibodies (none in the Java
population) (Yamanaka et al. 2010). In contrast to the
above-mentioned, only two human cases exist in
ProMED-mail in 2011 and 2015, whereas sero-surveil-
lance studies from 1999 to 2001 on Java Island detected
2.2% JEV antibodies (titres 1:160) involving over 2000
samples (Konishi et al. 2009).
A number of clinical studies report a noteworthy inci-
dence of JEV cases in children, of which a significant
number report subsequent neurological sequelae.
A study performed between 2001 and 2003, involving
all healthcare facilities on Bali island, reported an aver-
age incidence rate of 7.1 per 100 000 children aged 10
or below (Kari et al. 2006). Another study followed up
65 out of 72 cases of laboratory-confirmed JEV in chil-
dren between 2001 and 2004. In this study, a total of 16
children were deceased at the follow-up assessment
(average 13 months after discharge, range 4–24
months). No less than 25% of the children had sequelae
in such way, that they were dependent on their daily
functioning and only 25% of the children were consid-
ered to be fully recovered (Maha et al. 2009). A case-
control study of Liu et al. confirmed JEV in about one-
third of the clinically identified viral encephalitis
or aseptic meningitis in children aged 0–11 years.
Multivariate analysis revealed that pig ownership by
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their family, close proximity to the rice fields and older
age was significantly associated with the incidence risk
of JEV in children (Liu et al. 2010). No such studies seem
to have been carried out in adults in the past decade.
Despite being discussed at World Health
Organization’s meetings (Tsai 2000) and its relevance as
pointed out above, currently, no surveillance programme
nor a vaccination programme exist in Indonesia, even
while the latter was reported as cost-effective for a two-
dose regime on Bali island (Liu et al. 2008). To our know-
ledge, the MoH-RI is advancing towards implementation
of a childhood vaccine for JEV; it is, however, unclear
what a surveillance programmewill look like.
Chikungunya (CHIKV)
Chikungunya virus (CHIKV) is an Alphavirus belonging
to the Togaviridae family, transmitted in Asia by mos-
quitos of the Aedes family (Caglioti et al. 2013). After an
incubation period of 2–4 d (range 1–12 d) (Caglioti et al.
2013; Thiberville et al. 2013), the majority of the
infected patients become symptomatic. CHIKV is charac-
terized by an onset of acute febrile illness and maculo-
papular rash. Severe joint pain is described as main
symptom and is present in almost all cases; arthralgia in
specific cases can last up to 24 months (Kucharz and
Cebula-Byrska 2012; Thiberville et al. 2013). Treatment is
symptomatic. The re-emergence of CHIKV was reported
in Indonesia in serological studies in 1999 (Porter et al.
2004) and in outbreak reports from 2001 to 2003 (Laras
et al. 2005). Furthermore, CHIKV was isolated from
patient sera in febrile illness cases from prospective
cohorts from 2000 to 2008 – with incidence rates of
10.1/1000 CHIKV infections per person-years (Mulyatno
et al. 2012; Kosasih et al. 2013). When comparing MoH-
RI reported incidence numbers of CHIKV in 2014 (MoH-
RI 2015) to confirmed cases in a cohort study of
2010–2011, there is reason to believe that there is
underreporting of CHIKV in Indonesia. This is likely the
result due to the similarities in clinical presentation for
both DENV and CHIKV (Mulyatno et al. 2012), the sparse
availability of routine diagnostics and not the trends in
the CHIKV outbreak Figure 2 highlights these trends for
CHIKV, avian influenza, and rabies. Both MoH-RI and
ProMED-mail data are prone to reporting bias; the fig-
ure shows clear trends and discrepancies in reporting
between MoH-RI and ProMED-mail. For CHIKV, there
seems a fixed ratio of ProMED-mail reports versus MoH-
RI data in 2007 and 2008, whereas in later years, it is
definitely questionable how to adequately assess the
real incidence numbers, since ProMED-mail numbers
decline and MoH-RI numbers both drop and raise.
Measles (MV)
Measles virus (MV), a Morbillivirus belonging to the
Paramyxoviridae, is a highly contagious virus, with
the number of new infections that can result from one
infected person ranging from 12 to 16 (also referred to
in literature as the R0). It spreads directly from human
to human by virus-containing aerosols. Especially at risk
are people naïve to the virus, being those not vacci-
nated and children losing passive antibodies after birth.
The infection is characterized by illness with fever,
cough, coryza, conjunctivitis, and Koplik’s spots. A char-
acteristic erythematous and maculopapular rash
appears which lasts for 3–5 d (Moss and Griffin 2012). In
40% of the cases, measles infection is complicated, for
instance by pneumonia, due to a relative immunosup-
pression after measles virus infection (de Vries et al.
2012; Mina et al. 2015). The incidence number of MV is
successfully being reduced by vaccination, although
outbreaks do occur, both in countries with and without
vaccination programme due to vaccine effectiveness
and vaccine coverage (WHO 2012; Durrheim et al.
2014). The implementation of a regular immunization
programme for MV led to vaccination coverages above
90% in most of Indonesia, a target as set by WHO, with
a declining number of provinces not meeting this target
over the past years (Dalimunthe et al. 1990; Serquina-
Ramiro et al. 2001; MoH-RI 2014). When comparing
these data to WHO reports, it can be depicted that the
overall 1st dose coverage among one-year-olds is still
below the 90% target (WHO 2016a). Also, ProMED-mail
reports show no evidence of MV outbreaks, while MoH-
RI still reports a number of cases totalling to an
incidence rate of about 5–6 per 100 000 inhabitants
(MoH-RI 2014, 2015).
Rabies (RABV)
Rabies (RABV) is caused by a number of Lyssaviruses
including the rabies virus and bat Lyssaviruses. Saliva
from infected animals can transmit the virus to humans
and eventually cause a lethal infection of the brains. In
the majority of cases, dogs transmit the virus; however,
transmission of rabies via other wildlife should be taken
into consideration (Wang et al. 2014). RABV causes an
estimated number of deaths between fifty and a hun-
dred thousand per year. The Asian and African conti-
nent account for 95% of the worldwide deaths of the
total reported infections (Leung AK et al. 2007).
RABV is endemic in Indonesia, especially in Bali and
East Nusa Tenggara and is likely present since the
1880s, based on multiple manuscripts describing clinical
cases following bites from “mad dogs” (Ward 2014).
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After being last described in late 1980s (Waltner-Toews
et al. 1990) an outbreak in Bali and surrounding islands
commenced in 2008 (MoH-RI 2009). Up to hundred
human cases and a case fatality rate of 100% in labora-
tory confirmed human cases were reported during the
outbreak until 2010 (Susilawathi et al. 2012). Of interest
is the data from GeoSentinel and EuroTravNet sites;
12.1% of all post-exposure prophylactic vaccination for
RABV was requested by travellers returning from Bali.
However, their data shows that the majority of animal-
related injuries in travellers returning from Bali are asso-
ciated with exposure to monkeys, and not dog bites/
scratches (Gautret et al. 2011). Figure 2 shows trends in
RABV reporting to MoH-RI and ProMED-mail. The trends
in reporting to both entities are less well correlated as
compared to those in CHIKV. Figure 3 shows outbreak
locations in Bali as reported in ProMED-mail and com-
pared to MoH-RI incidence numbers. It could be benefi-
cial to combine Ministry of Health, ProMED-mail and
possibly WHO data to get a thorough overview of areas
at risk in case of outbreaks since locational data could
be of relevance for governmental interventions or
travel-related risks.
To further understand the endemic, a number of ani-
mal studies were carried out. During the 2008–2010
outbreak, Dibia and colleagues showed that Indonesian
RABV originated from Java Island and were (re-)intro-
duced in several other islands including Bali (Dibia et al.
2015). Also, a study has been conducted to estimate the
owned and unowned dog populations and dog bite
cases in (RABV free) Lombok island (Mustiana et al.
2015) in order to get insight in the (potential) spread.
From 2008, early preventive measurements to stop the
outbreak were implemented. Despite control – includ-
ing mass vaccinations and culling for dogs – the out-
break continued for four years. This largely had to do
with the fact that the dog population in Bali is rather
large and the human-dog relationship in Bali is believed
to be multifaceted (i.e. for cultural reasons, as guard,
but also different point-of-views in dog care and best
practices after a bite wound) (Widyastuti et al. 2015).
Also culling of dogs seemed to be ineffective. The
island-wide vaccination, aiming for a vaccine coverage
rate of 70% in dogs, did, however, reduce the incidence
and spread of rabies (Putra et al. 2013). Still, a number
of RABV cases are reported over the last years, as is
summarized in Figures 2 and 3.
Hantavirus (HV)
Hantaviruses (HV) belong to the family of the
Bunyaviridae. In humans, the rodent-borne HVs cause
two different diseases. In North and South America
inhalation of virus-containing aerosols with new world
hantaviruses could lead to the hantavirus cardio pul-
monary syndrome, a syndrome characterized by fever
Figure 3. Rabies outbreak heat map to demonstrate the benefit of combining Ministry of Health and ProMED-mail data.
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and acute respiratory distress associated with high case
fatality rates (Bi et al. 2008). Of importance for
Indonesia, seem to be the so-called Old-World HVs
which can cause haemorrhagic fever with renal syn-
drome (HFRS) (Watson et al. 2014). A triad of fever,
haemorrhage and acute kidney injury classically charac-
terizes this syndrome. It is crucial to initiate prompt and
proper symptomatic and supportive treatment for
HFRS. This includes monitoring of fluid balance, diuresis,
kidney function, and the use of fresh frozen plasma/
transfusions in case of haemorrhagic complications
(Goeijenbier et al. 2013). Small trials and case reports
have shown that ribavirin treatment may be useful in
the very early phase of HFRS by reducing the risk of
haemorrhagic events and the severity of renal insuffi-
ciency. Larger trials are needed to corroborate these
findings (Moreli et al. 2014). In routine diagnostics, Old
World HV infections are diagnosed by both serological
detection of IgM and/or IgG antibodies and molecular
detection of the virus. However, the extent of viremia
varies per HV species and in some cases might be lim-
ited to a short period after onset of illness (Bi et al.
2008). Currently, (comparative) virus neutralization tests
remain the gold standard in HV serology to confirm an
infection with a specific HV species. Neutralization tests
remain an absolute necessity since current available
serological HV diagnostics suffer from a high percent-
age of false-positive results, and, therefore, reports
solely relying on ELISA or IFA results should be inter-
preted with care (Goeijenbier et al. 2014). Earlier studies
suggested HV infection in humans and rodents in
Indonesia (Ibrahim et al. 1996; Plyusnina et al. 2004;
Plyusnina et al. 2009; Kosasih et al. 2011; Ibrahim et al.
2013) and a number of cases were found in hospital-
based cohort studies conducted between 1995 and
2005 (Groen et al. 2002; Suharti et al. 2009; Kosasih
et al. 2011). However, this evidence of human HV infec-
tion in Indonesia is based on only IgM ELISA proven
cases. For instance, Suharti et al. report ELISA response
of a recent infection in 4.2% of DENV suspected patients
(Suharti et al. 2009). Although not conclusive, this data
does suggest symptomatic human HV infection in
Indonesia, which is also supported by the results of
Groen et al. who reported serological evidence, based
on EIA, ELISA, and IFA results in 11% in a DENV sus-
pected cohort (Groen et al. 2002). Furthermore, sero-
logical evidence of HV infection was reported in a
clustered case of 2005 in Western Java (Kosasih et al.
2011). In this case, Rattus sp. trapped around the living
area of the patient showed the molecular presence of
Seoul HV, known to cause HFRS in Europe. Seoul virus
has been detected by PCR in Rattus norvegicus, the
known reservoir of the pathogenic Seoul virus
(Plyusnina et al. 2004).
Furthermore, a newly discovered HV in the Thousand
Island region in Indonesia might be pathogenic to
humans (Ibrahim et al. 2013). Urgent studies are needed
to estimate the burden of HV disease in humans in
Indonesia and for adequate prevention methods (i.e.
rodent trapping and human behaviour changes).
Avian influenza (AI)
Avian influenza (AI) infection in human, caused by non-
seasonal influenza A viruses of the subtypes H5N1 and
H7N9 belonging to the Orthomyxoviridae family, is clin-
ically characterized by respiratory disease. The first AI
H5N1 reported cases date from 1997 influenza in Hong
Kong. Since then, the virus has spread throughout the
South East of Asia with Indonesia being hit the hardest
(WHO 2015a). In Indonesia, the epidemic in poultry
started in December 2003 on Java Island, with now 31
out the 33 provinces being considered endemic. AI in
humans was first detected in July 2005. Despite control
measures to prevent further transmission among
poultry, the infection rate among humans declined
from 5 to 3 cases per month in the reports of 2008.
Up to 2015, a total of 195 cases have been WHO con-
firmed in Indonesia, of which 165 were fatal – mainly in
the period of 2005–2009 (Sedyaningsih et al. 2008;
WHO 2015a). Reports over 2014 show a continuation of
the decline and only 2 cases are reported in the archi-
pelago (MoH-RI 2015). Refer to Figure 2 for an overview
of MoH-RI reports and trends in ProMED-mail reporting
of AI. The importance of early ProMED-mail reports is
clearly shown here, as the number of reports constantly
seems to exceed MoH-RI data, which could indicate
impaired implementation of a governmental pro-
gramme (underreporting to the government).
Unfortunately, one cannot rule out (unverifiable) over
reporting in ProMED-mail.
Transmission of the disease is considered to be
caused by direct exposure to infected poultry. Several
family case clusters (Kandun et al. 2008) have been
reported suggesting the possibility of human-to-human
transmission in a study of Yang et al. (2007). However,
transmission estimates were only based on one cluster.
In addition, blood relatives were shown to be at risk of
infection in household outbreaks, supporting the
hypothesis for genetic host susceptibility (Aditama et al.
2011; Aditama et al. 2012). Recent data showed that
only a couple mutations in current circulating highly
pathogenic AI H5N1 viruses, would be enough to
enhance human-to-human airborne transmission (Herfst
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et al. 2012). This illustrates the pandemic potential and
possible concerns for international public health.
Several measures have been taken to control disease,
comprising vaccination of poultry, and implementation
of a participatory disease surveillance (PDS) programme,
a community-based reporting system (Azhar et al. 2010;
Mariner et al. 2014). At the beginning of the outbreaks,
control of disease has been problematic due to poor
gathering of epidemiological information. Since the
start of PDS, registration of new cases has been greatly
enhanced. Taking social and cultural context of dynam-
ics and distribution of disease into account have been
valuable in this process (Mariner et al. 2014).
Hepatitis A (HAV)
Indonesia was generally considered to be part of the
Hepatitis A (HAV) endemic regions of the world. This
food-borne infection with HAV, related to decreased
sanitation conditions, infects over 90% of children
under the age of 10 years in endemic regions (Barzaga
2000). Since the infection before the age of five is rather
asymptomatic, the burden of disease for inhabitants in
endemic regions is rather low, resulting in a high level
of community-based immunity for acute HAV infections.
Therefore, hardly any outbreaks occur within the com-
munity. In upcoming economies like Indonesia, how-
ever, the number of infected children drops with a
subsequent increase in symptomatic infections on an
older age as a results of a clear increase in level of sani-
tation (Vranckx et al. 1997). This decline in seropreva-
lence amongst children and adolescents has been
reported in Indonesia and other countries on the con-
tinent (Kunasol et al. 1998). This change in epidemio-
logic pattern has clinical and public health implications,
where at some point the introduction of nation-wide
HAV vaccination might be cost-effective compared to
treatment of acute HAV infection (Suwantika et al. 2014),
which is symptom driven. For persons traveling to
Indonesia, HAV vaccination is generally recommended
by travel medicine guidelines (refer to Table 1) – espe-
cially for adults, and imported cases of HAV from travel-
lers to and from Indonesia have been broadly reported
in literature (Boggild et al. 2010; Utsumi et al. 2014).
Seasonal influenza and influenza-like illnesses
Influenza viruses, the most well-known members of
Orthomyxoviridae family, cause respiratory disease in
humans predominantly. Those mimicking the symptoms
of Influenza are known as non-influenza viruses, causing
influenza-like illnesses. Of the three influenza virus types
(A, B, and C), influenza A is the best known for its ability
to drift, re-assort, and the cause of seasonal human flu
on a yearly base. Influenza A affects 5–15% of the
human population every year. In the tropical Indonesia
climate, no true seasonality of influenza is present
(Nicholson et al. 2003). The virus seems to be constantly
present and cause respiratory disease throughout the
whole year. However, Storms et al. studied the preva-
lence of influenza virus in patients seeking care for
respiratory disease in Jakarta, Java over a one-year
period starting in 2011 and reported the highest inci-
dence during December–May with the proportion of
positive PCR being 76% for patients presenting with
classic influenza-like illness. Of those, 36% had more
severe disease during the weeks with highest influenza
activity (Storms et al. 2015). Most likely, seasonality
exists in line with rainy season. Currently, no country
-based policies regarding influenza vaccination (such as
for risk groups, healthcare professionals, etc.) are imple-
mented in Indonesia.
MoH-RI discusses the recommendation of antivirals
like oseltamivir or vaccination policies in Indonesia,
since several studies report this high percentage of
complicated influenza cases in Indonesia (up to 15%)
(Kosasih et al. 2014; Ampofo et al. 2015; Storms et al.
2015). Of interest for clinicians dealing with travellers
with travel plans to Indonesia, comes from data of the
Geosentinel network. It shows that travellers travelling
to South East Asia have a sevenfold higher change of
being infected with seasonal influenza compared to
those staying at home (Boggild et al. 2012). It, therefore,
seems reasonable to vaccinate travellers and inhabi-
tants; however, a yearly seasonal influenza vaccine is
currently not implemented in any Indonesian immun-
ization schedule (Table 1) (Goeijenbier et al. 2017).
During a one-year study from 2008, just above 200
respiratory specimens from patients hospitalized in
Indonesia (total 1222 patients including hospitals in
Thailand and Vietnam) with suspected influenza or
influenza-like illness were collected and analysed. In the
cohort, 18.7% of the samples tested positive for
Rhinovirus, in particular in March. Furthermore, respira-
tory syncytial virus (RSV, 11.8%) was found from July to
November. Other detected viruses included bocavirus
(16.4%), parainfluenza (11.5%), adenovirus (8.4%),
influenza A and B (7.6%), and coronaviruses (1.8%)
(Wertheim et al. 2015).
Zika virus infection, hepatitis E, MERS corona
Three cases of Zika virus infection, caused by a
Flavivirus transmitted by Aedes aegypti mosquitoes, in
Indonesia are reported in literature. These infections,
clinically characterized by fever, headache, malaise,
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arthralgia, myalgia, and rash, were all documented in
returning travellers from Jakarta (2012, after 9-d holi-
day) (Kwong et al. 2013), Bali (2013, after monkey bite
in Ubud Monkey Forest) (Leung GH et al. 2015), and
Malaysian Borneo (2014, after a 3-week holiday) (Tappe
et al. 2015).
Also, seven cases of probable Zika virus infection in
inpatient inhabitants of Central Java were reported
based on antibody diagnostics (Olson et al. 1981). In
samples collected in 2014–2015, during a DENV out-
break in Jambi (n¼ 103), one DENV negative sample
was tested positive for Zika (Perkasa et al. 2016). Once,
a monkey bite was proposed as a route of transmission,
while Zika is generally considered to be a mosquito-
borne disease (Leung GH et al. 2015). Since both DENV
and Zika manifest clinically similar, it remains unclear
whether Zika virus infection is rare in Indonesia or is
often mistaken for DENV. Only limited, if none, diagnos-
tics are carried out to Zika and no regular surveillance
programmes exist (MoH-RI 2015).
Three outbreaks of hepatitis E infections, transmitted
faecal-orally and associated with low standards of sani-
tation, have been described in West-Kalimantan and
Java (Corwin et al. 1995; Corwin et al. 1997;
Sedyaningsih-Mamahit et al. 2002). All three outbreaks
were related to dependence to polluted river water.
Anti-hepatitis E virus seropositivity is shown to be more
prevalent in regions where pigs and swines are more
incorporated in daily life, as is the case in Bali Island,
compared to Java. Samples were taken from farms in
Yogyakarta (Central Java), Tulungagung (East Java) and
Mengwi (Bali) (Utsumi et al. 2011; Widasari et al. 2013).
Also, hepatitis E virus has been detected in wild rats,
however, whether their role in human infection is sig-
nificant or not remains unclear (Mulyanto et al. 2013).
Middle East respiratory syndrome corona virus
(MERS-CoV) causes upper respiratory infections in
humans with case fatality rates up to 35%. MERS-CoV is
prevalent in Arabian countries, including Saudi-Arabia,
which is visited by Indonesian inhabitants for hajj (pil-
grimage) (Widagdo et al. 2017). So far, no cases of MERS
corona virus infections in Indonesia are reported in
literature.
Implications and future actions
Summarized data from scientific literature, WHO
reports, reports from the Ministry of Health of the
Republic of Indonesia and ProMED-mail, presented in
this review, provide a unique insight in the past, current
and potential of relevant viral pathogens for the
Indonesian archipelago. Indonesia seems to be prone
to vector-borne and zoonotic diseases, due to
environmental conditions suited for arthropod vectors
and the presence of reservoirs for zoonotic viruses.
Viruses like DENV have been endemic for many years
while re-emergence of AI and RABV have drawn atten-
tion from governmental institutes and scientists.
Relevant for this region, but underreported in MoH
reports and literature are HV, HAV, and JEV.
Furthermore, only limited data is available about the
incidence of influenza and influenza-like illnesses –
while these viruses are known to have a significant bur-
den on society in due to economical losses.
Furthermore, these viruses most likely account for a
substantial number of hospital admissions for the very
young or elderly, as they do in Europe and USA.
The description of a (re-)emerging virus is expected
to happen in the order of ProMED-mail reports, scien-
tific studies and governmental data (MoH-RI and CDC or
WHO). Only parts of the ProMED-mail data regarding
outbreak reports were confirmed or became of scientific
interest in cohort studies (i.e. this holds especially true
for avian influenza). Ministry of Health (MoH-RI) data
seems to be partially in line with these findings.
ProMED-mail has proven to be a valuable tool in the
(early) detection of outbreaks all over the world. For
Indonesia, this is very well illustrated with AI reports, for
which, in many cases, the ProMED-mail reports are
ahead of official statements and literature. Interestingly,
ProMED-mail reporting for the rabies outbreak in Bali
started in 2010 (Figure 2), while most likely the out-
break started in 2008. Given the goal of ProMED-mail to
report emerging diseases on a low-threshold base, it
relies heavily on the awareness and possibilities to
report (unknown) cases by local healthcare workers.
This shows the importance for adequate on-site
diagnostics and surveillance programmes. To our
experience, the rabies under reporting seems to be an
exception in ProMED-mail.
We noticed some discrepancies in MoH-RI data as
compared to WHO and CDC data. In MoH-RI data it is
not always clear whether data was not available (i.e. not
reported to the government) or no cases occurred at
all. Furthermore, limited insight is given in number of
suspected cases versus laboratory-confirmed cases. In
case of RABV, the number of suspected cases (as meas-
ured by the number of animal bites) versus administra-
tion of RABV vaccine and number of confirmed and fatal
cases is reported. Information about the used diagnostic
methods lacks, as well as the number of tested samples
versus laboratory confirmed samples. Since data is not
available for local persons exposed to RABV, it is impos-
sible to draw conclusions based on these observations.
However, we do know, with special focus on Bali Island,
that RABV post exposure is the number two most
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prevalent post-travel health care problem in travellers
as per Geosentinel data – just above influenza and
below travellers’ diarrhoea. The number of actual RABV
cases, luckily, is actually one of the more rare problems.
We also observed over reporting in ProMED-mail, as
only few reports of DENV in ProMED-mail exist but doz-
ens of reports for CHIKV and AI were added; we were
unable to settle this discrepancy, moreover, both are
reported to the government and taken to MoH-RI
reports over the past years. ProMED-mail entries should
be interpreted with care, as its form is prone to report-
ing bias and no peer-review system exists.
There is a clear unmet need for cohort studies in a
number of primary, secondary, and tertiary care centres
evenly spread over the archipelago. In particular, some
well-studied acute viral diseases, such as influenza and
influenza-like illnesses are only limitedly researched in
Indonesia. Furthermore, up-to-date scientific informa-
tion regarding for instance HAV and MV antibody preva-
lence – and hence – the risk for those unvaccinated
seems to lack for this region.
Incidence numbers as reported in scientific studies
serve a different purpose than those reported in MoH-RI
(or CDC, WHO) data, due to the selection of a specific
population (i.e. a poultry market, hospital-based, or clin-
ical symptoms). These data should guide healthcare
workers in their decisions when assessing patients in
the general practice or emergency department.
Healthcare workers should, therefore, be able to rely on
solid surveillance data from the MoH-RI as well as scien-
tific literature.
In recent years, CHIKV (2013, Caribbean islands),
Ebola (2014, West Africa), and Zika (2015, South
America and 2016, Asia), have proved to be of relevance
for both developed and developing countries. No
exception exists for Indonesia, especially since
Indonesia is an upcoming economy and a popular
travel destination. Vector control is relevant in order to
control outbreaks. The MoH-RI sets targets to lower the
number of larvae around houses as well as targets for
lowering the incidence rate for new cases (e.g. DENV)
on a yearly base. Next, to this challenging task, there is
need for a functional and validated surveillance pro-
gramme. Government reference laboratories are only
available in limited numbers and the geographic layout
in terms of the archipelago, including distant areas, and
a variety in both economic strength and availability of
health care facilities, poses another challenge to get an
accurate oversight EIVD epidemiology.
Changes to the Indonesian vaccination programme
will be needed to be made in the future, as new vac-
cines and epidemiological data become available. This
especially holds true for new DENV vaccines and
existing JEV (refer to Table 1, comparing the MoH-RI
immunization scheme to travel immunization advice).
Preparedness for EI(V)Ds can only be achieved with an
adequate insight and control of current pathogens, a
solid surveillance system including reference laborato-
ries and the ability to scale up the resources needed to
adequately diagnose, treat, and follow-up patients.
To our findings, resources should be directed to the
One Health concept as it is of utmost importance to
achieve the correct balance for people, animals, and the
environment. Given recent outbreaks in the world, the
existence of vectors in Indonesia and the ability to
spread diseases in humans, poultry, or goods, it might
just be a matter of time before other well-known viral
diseases, such as yellow fever or other emerging dis-
eases will be engrafted in Indonesia.
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